Abstract:The bioequivalence study was conducted to compare the bioavailability of two rosuvastatin 20 mg film-coated tablet formulations (test and reference formulation). This study was an open-label, randomized, single-dose, two-periods, twotreatments, and crossover study which included 32 healthy adult male and female subjects under fasting conditions. Each of the two study periods was separated by a 7 days washout period. A single oral dose of test or reference drug was administered to the subject in each period based on the randomization scheme. Plasma concentrations of the drug were determined by LC-MS/MS method. The pharmacokinetic parameters assessed in this study were the area under the plasma concentration-time curve from time zero to 72 h (AUC0-72h), area under the plasma concentration-time curve from time zero to infinity (AUC0-∞), the peak plasma concentration of the drug (Cmax), time needed to achieve the peak plasma concentration (Tmax), and the elimination half-life (T1/2). The geometric mean ratio (GMR) and 90% Confidence Interval (90% CI) for AUC0-72h and Cmax of test/reference drug for rosuvastatin were 97.05 % (89.07%– 105.74%) and 101.15% (89.53%– 114.26%). Since the 90% CI with α 0.05% for AUC0-72h and Cmax of rosuvastatin were within the standard bioequivalence range (80.00– 125.00%), it was concluded that the two rosuvastatin film-coated tablets (test and reference drug) were bioequivalence in terms of the rate and extent of absorption.

Study of Pharmacokinetics and Bioequivalence of Rosuvastatin Capsules by High Performance Liquid Chromatographic-Mass Spectrometry

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

HPLC-MS/MS Study on Determination of Rosuvastatin Calcium in Human Plasma and Its Bioequivalence

An Accurate, Rapid and Sensitive LC-MS-MS Method for Quantification of Rosuvastatin in Human Plasma: Application to a Bioequivalence Study

Clinical Study for Dose-Effect and Safety of Rosuvastatin in Patients with Primary Hypercholesterolemia

Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single‐dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions

Bioequivalence Study of Simvastatin Tablets in Healthy Chinese Volunteers by UPLC-MS/MS

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Pharmacokinetics and bioequivalence of roxithromycin capsules in human

Study of Pharmacokinetics and Relative Bioavalability of Roxithromycin

Study on Pharmacokinetics and Bioequivalence of Roxithromycin

Bioequivalence Study Comparing a Generic and Innovator Drug of Rosuvastatin 20 mg

Determination of Pharmacokinetics and Bioequivalence of Simvastatin Tablets with LC-MS/MS in Chinese Healthy Volunteers

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Determination of Rosuvastatin Concentration in Human Plasma by LC-MS Method

Pharmacokinetics of rosuvastatin calcium tablets in Chinese healthy volunteers after a single oral dose administration

Study on bioequivalence and pharmacokinetics of compound glycyrrhizin capsules in healthy volunteers

Bioequivalence of Rosiglitazone in Healthy Volunteers

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

Determination of Glucosamine Sulfate in Human Plasma by LC-MS/MS and Study on Its Bioequivalence